Skip to main content
. Author manuscript; available in PMC: 2023 Jan 20.
Published in final edited form as: J Psychosoc Oncol. 2022 Mar 21;41(1):87–103. doi: 10.1080/07347332.2022.2046676

Table 2.

Medical characteristics (N = 327).

N (%) M (SD) n (Missing)
cancer Diagnosis 1
First/Initial 317 (97.2%)
Recurrence 9 (2.8%)
Months Since Diagnosis 10.11 (6.21) 0
Stage 0
I 183 (56.0%)
II 113 (34.6%)
III 31 (9.5%)
Breast Surgery History
Mastectomy – one breast 54 (16.7%) 3
Mastectomy – two breasts 65 (20.1%) 3
Breast Conserving Surgery 185 (56.9%) 2
Lymph Node Removal 286 (88.3%) 3
Reconstruction 73 (22.5%) 3
Receipt of chemotherapy 27 (8.3%) 1
Receipt of Radiation 35 (10.8%) 2
Receipt of surgery 22 (6.7%) 1
Receipt of endocrine therapy 49 (15.1%) 3
Receipt of immunotherapy 31 (9.6%) 4
Antidepressant medication use 123 (37.7%) 1
Pain medication use 212 (64.8%) 0
Days with pain medication use 4
0 118 (36.5%)
1 15 (4.6%)
2 22 (6.8%)
3 34 (10.5%)
4 28 (8.7%)
5 18 (5.6%)
6 3 (.9%)
7 85 (26.3%)
Type of pain medication
OTC 177 (54.1%) 0
Opioid 60 (18.3%) 0
Corticosteroid 8 (2,4%) 0
Anti-epileptic (e.g, Neurontin) 30 (9.2%) 0
Anxiolytic 48 (14.7%) 0

Note. M = mean; SD = standard deviation; Breast-conserving Surgery includes lumpectomy, quadrantectomy, partial mastectomy, segmental mastectomy; Receipt of chemotherapy, radiation, surgery, endocrine therapy, and immunotherapy is for week before baseline assessment; OTC = over the counter.